ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Zentek corrects OTC trading start date to Sept. 2

Canadian firm Zentek Ltd. revised its OTC Markets debut to Wednesday after an error in its prior release. Shares remain listed on TSX Venture Exchange.

PA
Priya Anand · Equities & Earnings Desk · 31 Aug 2026 · 17:22 · 1 min read
Share
Zentek corrects OTC trading start date to Sept. 2

Zentek Ltd. corrected the start date for its planned quotation on the OTCQX Best Market to Wednesday, Sept. 2, 2026, following an error in its Aug. 28 press release that misstated the day of the week.

The Toronto-based intellectual property company, which develops graphene-enabled and advanced material technologies, had initially announced the transition from NASDAQ to OTCQX in its Aug. 28 release. The correction aligns the trading start date with the previously stated date of Sept. 2, 2026, effective at the opening of trading.

Zentek applied for quotation of its common shares on OTCQX and has completed all required filings and fee payments, the company said. Shares currently listed on NASDAQ under the symbol ZTEK will be quoted on an initial tier until the OTCQX application is finalized, at which point a new U.S. trading symbol is expected to be assigned and published.

The TSX Venture Exchange listing under ZEN remains the company’s primary exchange and is unaffected by the OTC transition. Shareholders are not required to take any action; existing share counts, certificates and book-entry positions will remain unchanged.

As of the Aug. 28 close, Zentek’s shares were last quoted at 0.77 Canadian dollars on the TSX Venture Exchange, unchanged from the prior session.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT